International Journal of Neuropsychopharmacology

Papers
(The TQCC of International Journal of Neuropsychopharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
STUDY ON THE INFLUENCE OF INTELLIGENT TEACHING MODE BASED ON EMOTION REGULATION ON THE TEACHING QUALITY OF AGRICULTURAL METEOROLOGY162
RESEARCH ON THE RELATIONSHIP BETWEEN THE NEW MODEL OF STATE-OWNED ENTERPRISE REFORM AND PSYCHOLOGICAL IDENTITY AND EMOTIONAL REGULATION78
Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study50
MENTAL HEALTH STATUS AND EMOTIONAL BEHAVIOR REGULATIONOF SCI-TECH JOURNAL EDITORS AND ITS IMPACT ON JOURNAL QUALITY38
PSYCHOLOGICAL ANALYSIS OF ENVIRONMENTAL FACTORS OF OIL SPILL IN SHENZHEN PORT35
A QUESTIONNAIRE SURVEY ON THE RELATIONSHIP BETWEEN EARLY ART EDUCATION AND EMOTION REGULATION OF CHINESE COLLEGE STUDENTS35
THE INFLUENCE OF ENTREPRENEURIAL EFFECT ON ENTREPRENEURSHIP FROM THE PERSPECTIVE OF EMOTIONAL BEHAVIOR CHANGE34
DORSAL CA3 NEURAL ACTIVITY MEDIATES WITNESSING STRESS- INDUCED RECOGNITION MEMORY DEFICITS IN ADOLESCENT MALE MICE32
CONTRIBUTION OF 5-HT2AR TO THE ANTI-ANHEDONIC AND NEUROPLASTICITY EFFECTS OF PSYCHEDELICS31
GUSHANSKAYA EKATERINA VLADIMIROVNA, PSYCHIATRIST, PSYCHOTHERAPIST, CANDIDATE OF MEDICAL SCIENCES, HEAD OF THE DEPARTMENT OF PSYCHIATRY AT THE PSYCHIATRIC HOSPITAL 13, ASSOCIATE PROFESSOR OF THE DEPART30
POSSIBLE IMMUNOLOGICAL PATHOPHYSIOLOGY IN BIPOLAR DISORDER: REVERSE-TRANSLATIONAL RESEARCH USING INDUCED MICROGLIA-LIKE (IMG) CELLS28
DEPRESSION AND ANTIDEPRESSANT USE IN PREGNANCY AND ADVERSE MATERNAL AND FETAL/CHILDREN OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS27
FACTORS ASSOCIATED WITH THE INITIATION OF LAXATIVE USE IN THE SAME PATIENTS WITH SCHIZOPHRENIA OVER A 20-YEAR PERIOD: RETROSPECTIVE COHORT STUDY24
NPAS4 ENHANCER RNA FORMS DNA:RNA HYBRID R-LOOP TO CONTROL REWARD-RELATED BEHAVIORAL ADAPTATION THROUGH ACTIVITY-DEPENDENT GENE EXPRESSION24
EVENAMIDE AS ADD-ON TREATMENT FOR TREATMENT-RESISTANT SCHIZOPHRENIA (TRS) PATIENTS NOT BENEFITING FROM ANTIPSYCHOTICS: DESIGN OF A PHASE 3, POTENTIALLY PIVOTAL, INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND24
EFFECTS OF MULTIPLE NEUROPSYCHIATRIC MEDICATIONS DURING PREGNANCY ON NEONATAL ABSTINENCE SYNDROME (SECOND REPORT)24
PROTOTYPIC ANTIDEPRESSANTS ACT AS A G-PROTEIN BIASED LPAR1 AGONIST AND CONTRIBUTE TO ANTIDEPRESSANT EFFECTS22
REGIONAL HOMOGENEITY CHANGES IN CEREBRAL AND CEREBELLAR REGIONS ASSOCIATED WITH DEFAULT-MODE NETWORK FOLLOWING PROLONGED INTERMITTENT THETA-BURST STIMULATION22
COURAGE AND TRANSFORMATION: PATIENT EXPERIENCES OF WEB- BASED EMDR FOR SUICIDAL IDEATION21
CB2 RECEPTOR IS ONE OF THE REGULATORY FACTORS OF THE AGE- RELATED CHANGES IN IMMUNE MECHANISM20
NEURAL ACTIVITY CHANGES VIA DOPAMINE D1 RECEPTOR STIMULATION IN THE NUCLEUS ACCUMBENS MODULATE MOTIVATION FOR WHEEL RUNNING IN MICE19
INHIBITION OF HISTAMINE METABOLIZING ENZYME IN THE BRAIN REDUCES CATAPLEXY IN NARCOLEPSY MODEL MICE19
(2R,6R)-HYDROXYNORKETAMINE TARGETING THE BASOLATERAL AMYGDALA REGULATES FEAR MEMORY18
303. PATIENT AND CLINICIAN ACCEPTANCE OF RECENT TECHNOLOGICAL ADVANCES IN THE THERAPEUTIC MONITORING OF LITHIUM18
FUNCTIONAL ANALYSIS OF IPS CELL-DERIVED NEURONS FROM A PATIENT WITH 3Q29 DELETION18
589. PERIPUBERTAL STRESS EXERTS DIFFERENTIAL IMPACTS ON THALAMIC RETICULAR AND REUNIENS NUCLEI IN MALE VS FEMALE RATS18
466. ASSESSING AND MANAGING CIGARETTE SMOKING AMONG PSYCHIATRIC INPATIENTS: CLINICAL AND SOCIODEMOGRAPHIC IMPLICATIONS17
680. ASSESSING THE UTILITY OF ZURANOLONE TO MODIFY ALCOHOL-RELATED BEHAVIOURS17
267. ETHNIC VARIABILITY IN RTMS DOSAGE: A CALL FOR ADAPTIVE THERAPEUTIC INNOVATION16
EXPLORATION OF LANDSCAPE PAINTING IN THE TREATMENT OF ANXIETY DISORDER IN ART EDUCATION16
272. EFFECTIVENESS OF TRANSCRANIAL PULSE STIMULATION FOR MAJOR DEPRESSION: PRELIMINARY EVIDENCE FOR CLINICAL RESPONSE AND NEUROIMAGING MECHANISMS16
329. DIFFERENTIALLY EXPRESSED PLATELET ONCOPROTEINS AND THEIR ASSOCIATION WITH PLASMA PROGRAMMED CELL DEATH LIGAND 1 IN BIPOLAR MANIC PATIENTS16
Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response16
370. ASSOCIATIONS OF POLYGENIC RISK SCORES DIFFERENTIATING ATTENTION-DEFICIT HYPERACTIVITY DISORDER FROM AUTISM SPECTRUM DISORDER WITH COGNITIVE AND CORTICAL ALTERATIONS IN SCHIZOPHRENIA PATIENTS15
467. THE NEUROANATOMY OF POSTPARTUM DEPRESSION: INSIGHTS FROM A CROSS-SECTIONAL STRUCTURAL MRI STUDY15
260. INSULIN-LIKE GROWTH FACTOR 1 IN THE BRAIN AND ADDICTION --- THE VULNERABLE PREFRONTAL CORTEX IN OPIOID USE DISORDER15
328. DELAYED ONSET POST-STROKE MANIA, A CASE REPORT AND LITERATURE REVIEW15
A Meta-Analysis of Neural Correlates of Reward Anticipation in Individuals at Clinical Risk for Schizophrenia14
IGF-1 Microinjection in the Prefrontal Cortex Attenuates Fentanyl-Seeking Behavior in Mice14
Aromatase Inhibition and Electroconvulsive Seizures in Adolescent Rats: Antidepressant and Long-Term Cognitive Sex Differences14
Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice14
495. USING SPATIALLY RESOLVED SINGLE-NUCLEUS MULTI-OMICS APPROACH TO UNDERSTAND HOW ADVERSITY CONTRIBUTES TO PSYCHIATRIC DISORDERS14
ASSOCIATION BETWEEN ALLOSTATIC LOAD AND CARDIAC STRUCTURE IN ADULT PATIENTS WITH SCHIZOPHRENIA13
DEVELOPMENT OF A MULTIMODAL VR SYSTEM FOR CORTICAL FUNCTIONAL NETWORK ANALYSIS DURING MOUSE SOCIAL BEHAVIOR13
Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms13
PSYCHOSOMATIC SYMPTOMS IN TYPE 2 DIABETES PATIENTS: A NETWORK ANALYSIS13
A STUDY ON THE REGULATORY STATUS OF PSYCHEDELICS IN KOREA AND THEIR ADMISSIBILITY AS THERAPEUTIC AGENTS13
TREATMENT DISENGAGEMENT AND APD TREATMENT IN EARLY PSYCHOSIS: RESULTS FROM EPINET – THE LARGEST EP NETWORK IN THE USA13
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression13
RESEARCH ON CATERING SERVICE ENCOUNTER, RELATIONSHIP BENEFIT AND CUSTOMER VOLUNTARY PERFORMANCE FROM THE PERSPECTIVE OF EMOTIONAL BEHAVIOR CHANGE -- A CASE STUDY OF CATERING CONSUMERS IN TAIWAN AND MA12
WHAT IS RELATED TO COST, PRODUCT OR SERVICE - EMPIRICAL DATA AND MARKET SENTIMENT REGULATION ANALYSIS OF SERVICE-ORIENTED LISTED COMPANIES IN CHINA'S MANUFACTURING INDUSTRY12
THE INFLUENCE OF FAMILY CULTURAL CAPITAL ON MIGRANT CHILDREN'S ACADEMIC ACHIEVEMENT — FROM THE PERSPECTIVE OF EMOTIONAL REGULATION12
EXPLORING AND CONSTRUCTING AN EFFECTIVE EVALUATION MODEL OF NETWORK TEACHING FROM THE PERSPECTIVE OF EMOTION REGULATION12
IDENTIFICATION OF PSYCHOLOGICAL COMPLEXITY AND EMOTIONAL REGULATION FACTORS OF CONSTRUCTION PROJECTS IN CHINA12
EXPLORATION OF MOBILE MARKET: POPULATION DISTRIBUTION AND EMOTIONAL BEHAVIOR CHANGES IN SOUTHEAST AND SOUTH ASIAN COUNTRIES12
160. CHANGES IN QUALITY OF LIFE AND PRODUCTIVITY GAIN AMONG ESKETAMINE RESPONDERS IN A REAL-WORLD STUDY IN AUSTRALIA AND NEW ZEALAND11
163. RELATIONSHIP BETWEEN CLOZAPINE: NORCLOZAPINE RATIO AND COGNITIVE FUNCTION AND EMPLOYMENT STATUS IN TREATMENT RESISTANT SCHIZOPHRENIA11
Metabotropic Glutamate Receptor 5 as a Potential Biomarker of the Intersection of Trauma and Cannabis Use11
388. COMMON AND DISTINCT EFFECTS OF 10-HZ RTMS AND ITBS ON STRIATUM-BASED FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER: A SHAM-CONTROLLED STUDY11
176. ANALYSIS OF THE EFFECT OF OXYTOCIN ANALOGUES ON A MOUSE CONTEXTUAL FEAR-CONDITIONING BEHAVIOR11
CANNABINOID RECEPTOR TYPE 1-REGULATED CELL DEATH DEPENDING ON ITS SUBCELLULAR LOCALIZATION IN HUMAN NEUROBLASTOMA CELL11
ON THE LONG-TERM CONSTRUCTION OF IDEOLOGICAL AND POLITICAL EDUCATION SYSTEM IN COLLEGES AND UNIVERSITIES GUIDED BY THE STATUS AND VALUES OF NATIONAL SENIOR OFFICIALS—BASED ON STUDENTS' EMOTIONAL BEHAV11
522. TARGETING OPIOID NEUROTRANSMISSION IN BORDERLINE PERSONALITY DISORDER WITH SELF-HARMING BEHAVIOR: PRELIMINARY FINDINGS OF A [11C]NOP-1A POSITRON EMISSION TOMOGRAPHY STUDY11
233. DYNAMIC POSTURAL CONTROL IN REMITTED BIPOLAR I DISORDER: A CDP STUDY11
Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls11
THE IMPACT OF BALANCING DOMESTIC AND FOREIGN TAX SYSTEMS ON ALLEVIATING TAXPAYERS' INEQUALITY AND ANXIETY11
Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies10
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 310
Adjunctive Brexpiprazole in Patients With Unresolved Symptoms of Depression on Antidepressant Treatment Who are Early in the Disease Course: Post Hoc Analysis of Randomized Controlled Trials10
DISTRIBUTION OF DOPAMINE PATHWAY GENE POLYMORPHISMS IN SUBJECTS WITH DIFFERENT SMOKING BEHAVIOR10
Default Mode Network Modulation by Psychedelics: A Systematic Review10
545. DEFICIENCY OF TBX1, A GENE ENCODED IN 22Q11.2 COPY NUMBER VARIATION, IMPAIRS SOCIAL AND COGNITIVE BEHAVIORS BY ALTERING BRAIN SHAPE AND NEONATAL STEM CELLS10
421. THE RELATIONSHIP BETWEEN SLEEP QUALITY AND NEUROCOGNITIVE FUNCTION IN THE GERIATRIC DEPRESSION: A CASE-CONTROL STUDY10
The D2-like Dopamine Receptor Agonist Quinpirole Microinjected Into the Ventral Pallidum Dose-Dependently Inhibits the VTA and Induces Place Aversion10
A STUDY ON THE CORRELATION BETWEEN PSYCHOLOGICAL ANXIETY, SELF-EFFICACY AND FOREIGN LANGUAGE LEARNING ACHIEVEMENT10
108. SELECTIVE POTENTIATION OF α5-GABAA RECEPTORS CONTRIBUTES TO REDUCTION OF COGNITIVE BURDEN AND NEURONAL LOSS IN AGING MICE10
SOCIAL INTERACTION SUPPRESSES COCAINE RELAPSE BY REGULATING DAERGIC ENGRAM INPUT OF VENTRAL TEGMENTAL AREA10
EFFICACY EVALUATION OF TELEMEDICINE-BASED BIOPSYCHOSOCIAL MODEL: A RETROSPECTIVE STUDY IN CENTRAL CHINA10
EXPLORATION ON THE TEACHING REFORM OF “X-Y THEORY” IN THE DESIGN COURSE OF ENVIRONMENTAL DESIGN SPECIALTY BASED ON EMOTION REGULATION9
BASED ON ANXIETY SENSITIVITY AND ANXIETY INHIBITION: RECONSTRUCTION OF POST APOCALYPTIC SOCIETY9
EFFECTIVENESS AND SAFETY OF BLONANSERIN FOR IMPROVING SOCIAL AND COGNITIVE FUNCTIONS IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA9
IMPACT OF ANTIPSYCHOTICS ON PROLACTIN LEVELS IN PEDIATRIC AND ADOLESCENT PATIENTS WITH PSYCHIATRIC DISORDERS IN REAL-WORLD PSYCHIATRIC CLINICAL PRACTICE9
MATERNAL EXPOSURE TO AIR POLLUTANT PM2.5 INDUCES AUTISTIC-LIKE BEHAVIOR IN OFFSPRING9
EXPLORING THE NEUROBIOLOGICAL AND PSYCHOLOGICAL MECHANISMS OF KETAMINE IN PROBLEMATIC GAMBLING: A MECHANISTIC STUDY9
Corrigendum to: Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior9
RESEARCH ON YANGQIN PERFORMANCE OF HUNAN OPERA BASED ON THE COMBINATION OF HUTONG CULTURAL DEVELOPMENT AND STREET ART — FROM THE PERSPECTIVE OF EMOTION REGULATION9
ASSOCIATIONS OF CLOZAPINE AVAILABLE INSTITUTION AND THE DIAGNOSIS OF SUBGROUPS ABOUT TREATMENT-RESISTANT SCHIZOPHRENIA OR NOT WITH A HIGHER RATE OF ANTIPSYCHOTIC MONOTHERAPY AND LOWER OTHER CONCOMITAN9
DEVELOPMENTAL NICOTINE EXPOSURE AND COGNITIVE VULNERABILITY: IS THE IMMUNE SYSTEM INVOLVED?9
CONNEXIN43 IN NEONATAL EXCITATORY NEURONS IS IMPORTANT FOR MOTOR LEARNING9
A DIACHRONIC CASE STUDY OF ENGLISH TEACHERS' ONLINE EMOTION REGULATION9
STUDY ON CIVIL LITIGATION PSYCHOLOGY AND LEGAL IDENTITY FROM THE PERSPECTIVE OF EMOTIONAL BEHAVIOR REGULATION9
Investigation of Neurofunctional Changes Over the Course of Electroconvulsive Therapy9
THE IOWA GAMBLING TASK NET SCORES IS ASSOCIATED WITH SOCIAL FUNCTION IN BIPOLAR DISORDER9
IMPLICIT MEMORY AND EXPLICIT MEMORY PROFILES COMPARISONS BETWEEN PATIENTS WITH DIFFERENT MOOD DISORDERS9
EFFICACY OF LOW-DOSE INTERLEUKIN 2 AS ADD-ON IN THE TREATMENT OF UNIPOLAR AND BIPOLAR DEPRESSION9
ANALYSIS OF DOPAMINE TRANSPORTER-EXPRESSING NEURON-SPECIFIC TYROSINE HYDROXYLASE KNOCKOUT MICE8
Erythrocyte Membrane Fatty Acid Composition as a Potential Biomarker for Depression8
661. A SINGLE DOSE OF LYSERGIC ACID DIETHYLAMIDE (LSD) REDUCES ALCOHOL CONSUMPTION AND REVERTS DOPAMINERGIC (DA) DISFUNCTION IN MALE MICE8
A RETROSPECTIVE COMPARATIVE STUDY OF CLINICAL RESPONSE TO CLOZAPINE BETWEEN PATIENTS WITH EARLY TREATMENT-RESISTANT SCHIZOPHRENIA (TRS) AND LATE TRS8
ANTI DIABETIC PERIPHERAL NEUROPATHY OF RED FRUIT (PANDANUS CONOIDES LAMK) OIL IN A RAT MODEL: INVOLVEMENT OF OXIDATIVE AND NEUROINFLAMMATORY PATHWAYS8
401. EXPLORING FUNCTIONAL CONNECTIVITY IN ANXIETY: THE ROLE OF THE HIPPOCAMPUS, INSULA, AND AMYGDALA DURING A KETAMINE INFUSION8
PREDICTION OF CLINICAL RESPONSE TO DONEPEZIL AND MEMANTINE IN PATIENTS WITH ALZHEIMER'S DISEASES BY USING EEG CONNECTIVITY8
255. UNVEILING THE COGNITIVE ENHANCING EFFECTS OF RS-D7, A NOVEL NDMAR MODULATOR, ON HIPPOCAMPUS-DEPENDENT LEARNING AND MEMORY IN MICE8
415. SHARED GENETIC ARCHITECTURES BETWEEN METHAMPHETAMINE USE AND OTHER PSYCHIATRIC DISORDERS8
458. EFFECTIVENESS OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE ON RELAPSE PREVENTION OF SCHIZOPHRENIA7
564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA7
A SURVEY OF PATIENT– PHYSICIAN COMMUNICATION REGARDING TREATMENT PROSPECTS AND GOAL SETTING IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN JAPAN7
ESTIMATING A PROBABILITY OF REDUCING RISKS ASSOCIATED WITH SMOKING CONVENTIONAL CIGARETTES USING THE THS2.2 (IQOS) TECHNOLOGY7
PLASMA PHOSPHOETHANOLAMINE LEVELS AS A BIOMARKER FOR MONITORING MAJOR DEPRESSIVE DISORDER7
548. DECODING THE BIOMOLECULAR LANDSCAPE OF PSYCHIATRIC DISORDERS FOR IMPROVING PATIENT STRATIFICATION7
211. C-REACTIVE PROTEIN AND RESPONSE TO ADD-ON DEXTROMETHORPHAN TREATMENT IN BIPOLAR DISORDERS: RESULTS FROM A PLACEBO-CONTROLLED TRIAL7
543. MODULATION OF BRAIN FUNCTIONS BY GLIAL RESET7
ET-1-INDUCED ATTENUATION OF MOR ACTIVITY DIFFERS BETWEEN MORPHINE AND FENTANYL7
EFFECTS ON THE THALAMUS AND INSULAR CORTEX DURING VOCAL EMOTION PROCESSING BY MODAFINIL AND BUPROPION: A PHARMACOLOGICAL MRI STUDY7
618. A RANDOMISED CONTROLLED TRIAL OF AN AI-ENABLED MENTAL HEALTH INTERVENTION FOR GENERALIZED ANXIETY DISORDER SYMPTOMS7
578. COLLECTING AND EVALUATING ANIMAL MODELS IN MENTAL HEALTH SCIENCE AND BUILDING AN ONLINE RESOURCE FOR RESEARCHERS: A WELLCOME INITIATIVE7
PSYCHOPHARMACOLOGICAL CHALLENGES FOR HIV/AIDS PATIENTS WITH A HISTORY OF SUBSTANCE USE DISORDER EXPERIENCING PSYCHOTIC DEPRESSION7
TNFR2 LEVEL CHANGES IN PATIENTS WITH ALCOHOL DEPENDENCE DURING EARLY WITHDRAWAL7
JOBS STRESS LEADS TO PROFESSIONAL BURNOUT IN ADDICTION SPECIALISTS7
DISRUPTION OF IMPULSIVITY BEHAVIORS IN CANNABIS USERS IN ADOLESCENTS AND YOUNG ADULTS: A META-ANALYSIS OF FUNCTIONAL NEUROIMAGING STUDIES6
THE NEURAL MECHANISM UNDERLYING THE ANTIDEPRESSANT EFFECTS ELICITED BY A SINGLE BOUT OF PHYSICAL EXERCISE6
EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION OF THE LEFT DORSOLATERAL PREFRONTAL CORTEX ON SYMPTOM DOMAINS IN MOOD DISORDERS6
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System6
Therapeutic potential of D-amino acid oxidase inhibitors for cognitive impairment associated with schizophrenia: learnings from luvadaxistat6
POGZ MUTANT MOUSE MODEL OF AUTISM SPECTRUM DISORDER SHOWS ABNORMAL NEURAL ACTIVITY IN THE ANTERIOR CINGULATE CORTEX DURING SOCIAL BEHAVIOR6
DOES COCAINE-INDUCED AGGRAVATION OF DEPRESSION ALTER MATE ATTRACTIVENESS IN MALES?6
ACTIVATION OF PREFRONTAL PARVALBUMIN INTERNEURONS AMELIORATES WORKING MEMORY DEFICIT EVEN UNDER CLINICALLY COMPARABLE ANTIPSYCHOTIC TREATMENT IN A MOUSE MODEL OF SCHIZOPHRENIA6
Effect ofMAOADNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission Tomography6
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers6
ANALYSIS ON THE CHANGES OF WOMEN'S ROLE EMOTION AND BEHAVIOR IN VARIOUS SOCIAL ACTIVITIES IN THE MING AND QING DYNASTIES6
EFFECTS OF ANTIPSYCHOTIC USE BY PATIENTS WITH SCHIZOPHRENIA ON DECELERATION CAPACITY AND ITS RELATION TO THE CORRECTED QT INTERVAL6
GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION6
KNOCKDOWN OF CONNEXIN43 POTENTIATES ANTIDEPRESSANT EFFECT ON BRAIN-DERIVED NEUROTROPHIC FACTOR EXPRESSION IN PRIMARY CULTURED ASTROCYTES6
Rolipram Ameliorates Memory Deficits and Depression-Like Behavior in APP/PS1/tau Triple Transgenic Mice: Involvement of Neuroinflammation and Apoptosis via cAMP Signaling6
PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?6
THE INFLUENCE OF DISSOCIATIVE RESPONSE ON CORTISOL LEVEL FOLLOWING CHILDHOOD AND LATER TRAUMA: A PATH ANALYSISTHE INFLUENCE OF DISSOCIATIVE RESPONSE ON CORTISOL LEVEL FOLLOWING CHILDHOOD AND LATER TRA5
KNOWLEDGE AND OPINIONS ABOUT THE USE OF PSYCHEDELICS AMONG PSYCHIATRISTS IN KOREA: PRELIMINARY RESULTS5
PLASMA GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) IN ASTROCYTES CONTRIBUTES TO INCREASES IN THE PREVALENCE OF AUTISM SPECTRUM DISORDERS (ASD)5
AN INSIGHT INTO GENETIC CONDITIONS ASSOCIATED WITH INTELLECTUAL DISABILITY IN INDONESIAN POPULATION5
THE FUNCTIONAL CONNECTIVITY CHANGES OF THE RIGHT AMYGDALA ASSOCIATED WITH ANXIETY IN SCHIZOPHRENIA AND THE PRODROMAL PHASE5
REGULATION OF THE TRANSITION BETWEEN MEMORY RECALL AND NON- RECALL BY HISTAMINE NEURON ACTIVITY5
LUMATEPERONE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND BIPOLAR DISORDER WITH ANXIOUS DISTRESS AND MIXED FEATURES5
PROLINE-RICH TRANSMEMBRANE PROTEIN 2 KNOCK-IN MICE PRESENT NIGROSTRIATAL DOPAMINERGIC HYPERACTIVITY AND INCREASED SUSCEPTIBILITY TO L-DOPA-INDUCED MOTOR DEFICITS5
MANIC BEHAVIOR MAY BE ATTENUATED BY MATRIX METALLOPROTEINASE-8 INHIBITOR VIA DECREASING NEUROINFLAMMATION IN A MOUSE MODEL OF BIPOLAR DISORDER5
PUTATIVE SEX DIFFERENCES IN THE EXCITABILITY OF BETA- ENDORPHIN AND NEUROPEPTIDE-Y-SECRETING NEURONS OF THE ARCUATE NUCLEUS5
THE SUCROSE INTAKE CHANGES STRESS-INDUCED BEHAVIOR VIA GLUCOSE METABOLISM AND NORADRENERGIC NEURONAL SYSTEM5
IRON DEPOSITIONS IN PREFRONTAL CORTEX INFLUENCES THE EFFECTIVENESS OF CORTICAL PAIRED ASSOCIATIVE STIMULATION IN HEROIN-DEPENDENT PATIENTS: A RANDOMIZED SHAM-CONTROLLED STUDY4
AGE OF ONSET AFFECTS RELAPSE OF ALCOHOL USE DISORDER: A 7- YEAR RETROSPECTIVE COHORT STUDY4
268. THE PRELIMINARY ANALYSIS OF YOGA THERAPY ON BURNOUT AMONG MEDICAL STAFF: A SINGLE-ARM PRE-POST INTERVENTION4
551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES4
BLUNTED CORTISOL RESPONSE TO ACUTE PSYCHOSOCIAL STRESS IN WOMEN WITH PREMENSTRUAL DYSPHORIC DISORDER4
THE IMPACT OF SLEEP JET LAG ON DEPRESSION DIFFERED BY SEX AND AGE ~ EVIDENCE FROM 27,916 TAIWAN BIOBANK PARTICIPANTS4
CONSTRUCTION OF MULTIMODAL HEALING SPACE BASED ON INDIVIDUAL EMOTIONAL BEHAVIOR CHANGES4
635. THE NEUROBIOLOGICAL FOUNDATION FOR PHYSICAL EXERCISE RECOMMENDATIONS IN REDUCING SYMPTOMS OF ADHD4
379. INCIDENCE OF PSYCHOSIS AND ITS RISK FACTORS AND MORTALITY IN NORTH KOREAN DEFECTORS COMPARED TO SOUTH KOREAN CONTROLS4
Activation of mTORC1 Signaling Cascade in Hippocampus and Medial Prefrontal Cortex Is Required for Antidepressant Actions of Vortioxetine in Mice4
ROLES OF CANNABINOID TYPE 1 RECEPTORS IN THE MICE PREFRONTAL CORTEX FOR OBJECT LOCATION MEMORY4
ADJUVANT CITHICOLINE AGAINST NEGATIVE SYMPTOMPS AND INTERLEUKIN 6 (IL-6) IN SCHIZOPHRENIA PATIENTS WITH RECEIVING RISPERIDONE TREATMENT4
ANXIETY-LIKE BEHAVIOUR STUDY IN ADULT RAT STRESS MODEL INDUCED BY LIGHT DOMINANT EXPOSURE IN CIRCADIAN RHYTHM DISRUPTION4
Examination of the relationship between D-amino acid profiles and cognitive function in individuals with mild cognitive impairment: a machine learning approach4
506. MAPPING PERIPHERAL MOLECULAR MECHANISMS ASSOCIATED WITH LONG-LASTING EFFECTS OF EARLY LIFE STRESS: A TRANSCRIPTOMIC SET-BASED APPROACH4
702. INNOVATIVE PERSPECTIVES IN NEUROPSYCHOPHARMACOLOGY: INSIGHTS FROM INDONESIA, NEWZEALAND AND AUSTRALIA4
VALUABLE INTERACTION WITH COGNITIVE REMEDIATION AND OPTIMAL ANTIPSYCHOTICS FOR RECOVERY IN SCHIZOPHRENIA (VICTORY-S): STUDY PROTOCOL FOR AN INTERVENTIONAL, OPEN-LABEL, RATER- BLINDED, RANDOMIZED COMPA4
RTMS OVER THE DORSOLATERAL PREFRONTAL CORTEX INCREASES THE SERUM PROBDNF/BDNF RATIO: A SHAM-CONTROLLED STUDY IN SUBJECTS WITH COCAINE USE DISORDER4
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from cl3
Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects3
707. EXPERIENCES WITH NITAZENE WITHDRAWAL3
CONFLICT EQUILIBRIUM PREFERENCE RANKING OF MULTIPLE DECISION MAKERS BASED ON CONFLICT RESOLUTION GRAPH MODEL AND EMOTION REGULATION3
Inhibition of hippocampal or thalamic inputs to the nucleus accumbens reverses stress-induced alterations in dopamine system function3
505. ROLE OF COGNITIVE FUNCTION IN FUNCTIONAL OUTCOME IN PSYCHOTIC AND AFFECTIVE INPATIENTS3
Antipsychotics, COVID-19, and Secondary Healthcare Databases: Revisiting the Pandemic3
601. GENETIC POLYMORPHISMS ASSOCIATED WITH OPIOID SENSITIVITY IN PATIENTS UNDERGOING PALLIATIVE CARE AND GENERAL ANAESTHESIA3
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine3
671. PRENATAL STRESS EXPOSURE SHAPES CORTICOGENESIS THROUGH CELL FATE AND GENE REGULATORY NETWORKS WITH IMPLICATIONS FOR NEURODEVELOPMENTAL DISORDERS3
ANXIETY SENSITIVITY BIAS AND COLLECTIVE ACTION PARADOX IN EPIDEMIC PREVENTION AND RESPONSE IN WESTERN COUNTRIES — AN ANALYSIS BASED ON INCOMPLETE INFORMATION LEARNING MODEL3
209. OXYTOCINERGIC INPUT FOXYTOCINERGIC INPUT FROM THE PARAVENTRICULAR NUCLEUS TO THE NUCLEUS ACCUMBENS CORE MODULATES METHAMPHETAMINE-CONDITIONED PLACE PREFERENCE3
Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress–Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling3
519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL3
Partial agonist antipsychotic drugs differentially interact with a secondary binding site at the dopamine D2 receptor3
555. M4 MUSCARINIC RECEPTOR ACTIVATION IN THE CENTRAL AMYGDALA REDUCES STRESS-INDUCED ALCOHOL SEEKING IN ALCOHOL PREFERRING RATS3
Neurobiological influences on event perception: the role of catecholamines3
DECODING THE LINK AMONG SCHIZOPHRENIA, METABOLIC SYNDROME, AND THE SEROTONIN/MELATONIN PATHWAY USING THE MK-801 MOUSE MODEL2
681. ENDOCANNABINOIDS AND INTRUSIVE MEMORIES: EVIDENCE FOR A ROLE OF ANANDAMIDE FROM TWO EXPERIMENTAL HUMAN STUDIES2
Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies2
Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use2
643. RESTING-STATE FUNCTIONAL CONNECTIVITY ASSOCIATIONS WITH SUICIDAL IDEATION SEVERITY IN TREATMENT-RESISTANT DEPRESSION2
Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex2
445. DISTINCTIVE ASSOCIATION PATTERNS BETWEEN TOPOLOGICAL PROPERTIES OF BRAIN STRUCTURAL NETWORKS AND SOCIAL COGNITION IN EUTHYMIC BIPOLAR DISORDER2
168. EXPLORING SAFE TAPERING OF ANTIPSYCHOTICS IN PATIENTS WITH REMITTED PSYCHOSIS: EMPLOYING ANIMAL MODEL AND COADMINISTRATION OF N-ACETYLCYSTEINE STUDY IN BENCH AND BESIDE2
THE MODERATING EFFECT OF JOB SEARCH INTENSITY ON POSTGRADUATES' COMPREHENSIVE ABILITY, EMPLOYMENT PERFORMANCE AND PSYCHOLOGICAL ANXIETY SENSITIVITY2
Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential2
AUTOMATED ANALYSIS OF RODENT BEHAVIOR USING INTELLIPROFILLER: A POTENTIAL TOOL FOR STUDYING NEURODEVELOPMENTAL DISORDER-LIKE MODEL MICE2
ASSOCIATION BETWEEN ADHD, METHYLPHENIDATE, AND PRECOCIOUS PUBERTY: A NATIONWIDE COHORT STUDY2
488. SALIENCE NETWORK ALTERATIONS RELATED TO PERSONALITY TRAITS IN ADOLESCENTS WITH EXCESSIVE SMARTPHONE USE2
201. DISCRIMINATION BETWEEN HEALTHY PARTICIPANTS AND PEOPLE WITH PANIC DISORDER BASED ON POLYGENIC SCORES FOR PSYCHIATRIC DISORDERS AND FOR INTERMEDIATE PHENOTYPES USING MACHINE LEARNING2
DEEP TRANSCRANIAL MAGNETIC STIMULATION TREATMENT FOR TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER: A CASE SERIES FROM THAILAND2
A MACHINE LEARNING APPROACH TO PREDICT THE THERAPEUTIC EFFICACY OF MOBILE NEUROFEEDBACK IN CHILDREN WITH ADHD2
AN EMPIRICAL STUDY ON CHINESE EFL LEARNERS' CROSS-CULTURAL SENSITIVITY BASED ON EDUCATIONAL EMOTION REGULATION2
367. DISCOVERING MARKERS OF INTRON RETENTION IN DEPRESSION AND ITS RESPONSE TO KETAMINE2
Corrigendum to: Naturally Derived Polyphenols Protect Against Corticosterone-Induced Changes in Primary Cortical Neurons2
307. THE EFFECT OF SODIUM BENZOATE TREATMENT FOR TREATMENT RESISTANT SCHIZOPHRENIA AND ITS ASSOCIATION WITH GLUTAMATE CONCENTRATION: A PILOT STUDY WITH PROTON MAGNETIC RESONANCE SPECTROSCOPY2
437. EVALUATING APELIN AS A POTENTIAL BIOMARKER IN MAJOR DEPRESSIVE DISORDER: CORRELATION WITH CLINICAL SYMPTOMATOLOGY2
Illicit substance exposure in pregnancy and infant mortality risk: a nationwide Taiwan study2
274. RETROSPECTIVE STUDY FOR CORRELATION WITH REDUCING ANTIPARKINSONIAN ANTICHOLINERGIC DRUGS AND ADVERSE EFFECTS2
CAUSAL ASSOCIATIONS BETWEEN SCHIZOPHRENIA AND CANCERS: MENDELIAN RANDOMIZATION ANALYSES2
ELEVATED MIDBRAIN INTERLEUKIN-6 AND IMPAIRED GOAL-DIRECTED BEHAVIOR IN OLD C57BL/6J MICE AFTER HINDLIMB UNLOADING2
PRACTICAL GUIDELINES ON THE USE OF CARIPRAZINE IN BIPOLAR 1 DISORDER: EXPERT CONSENSUS FROM SOUTHEAST ASIA2
ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A 30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE2
694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING2
SOURCES OF INFORMATION ABOUT COVID-19 VACCINES FOR CHILDREN AND ITS ASSOCIATIONS WITH PARENTAL MOTIVATION TO HAVE THEIR CHILDREN VACCINATED IN TAIWAN2
PREDICTING RELAPSE FROM THE TIME TO REMISSION DURING THE ACUTE TREATMENT OF DEPRESSION: A RE-ANALYSIS OF THE STAR*D DATA2
RESEARCH ON THE INNOVATION OF TEACHING MODE OF “FRESHMAN SEMINAR” IN APPLIED UNIVERSITIES UNDER THE CONCEPT OF OBE BASED ON THE CHANGE OF EMOTIONAL BEHAVIOR -- TAKING PHYSICAL EDUCATION MAJOR OF NANCH2
347. PREDICTING RTMS TREATMENT RESPONSE IN DEPRESSION: USE OF MACHINE LEARNING MODELS TO IDENTIFY THE ROLES OF METABOLIC AND CLINICAL FACTORS2
Thrombomodulin Improves Cognitive Deficits in Heat-Stressed Mice2
354. COGNITIVE FLEXIBILITY AS A POSSIBLE INDEX OF AGE-RELATED COGNITIVE DECLINE2
628. DOPAMINERGIC CONTROL OF COMPULSIVE EATING2
Sleep Deprivation Engages the Orexin/Hypocretin System to Regulate Food Reward Seeking2
324. THEORETICAL DRUG SELECTION FOR BPSD2
RAPID AND SUSTAINED IMPROVEMENT OF RESIDUAL ANHEDONIA SYMPTOMS IN PATIENTS WITH DEPRESSION USING ANALGESIC AGENT - DEZOCINE2
ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS AND TARDIVE DYSKINESIA: ANALYSIS BASED ON A SPONTANEOUS REPORTING SYSTEM DATABASE IN JAPAN2
VITAMIN D AND DEPRESSION2
241. NEUROPHYSIOLOGICAL INSIGHTS INTO OMISSION MISMATCH NEGATIVITY: EVIDENCE FROM MACRO CALCIUM IMAGING IN RAT AUDITORY CORTEX2
WHITE MATTER ABNORMALITIES AND COGNITIVE IMPAIRMENT IN BIPOLAR I DISORDER: A MULTI-STATE INVESTIGATION2
591. MUSCARINIC RECEPTORS AND THE MOLECULAR PATHOLOGY OF SCHIZOPHRENIA1
690. SERUM ELEMENTS AND OXIDATIVE STRESS INDICES ARE ALTERED IN TREATMENT-RESISTANT SCHIZOPHRENIA1
ANTIPSYCHOTIC AGENTS IN ANXIETY DISORDERS: AN UMBRELLA REVIEW1
Sedative and hypnotic effects of nuciferine: enhancing rodent sleep via serotonergic system modulation1
REGION-SPECIFIC PLASTIC CHANGES IN THE PREFRONTAL CORTEX DRIVE COMPULSIVE TASK PERFORMANCE1
RELATIONSHIP BETWEEN MORNING BLOOD MELATONIN LEVELS AND SLEEP PROBLEMS IN 5-YEAR-OLD CHILDREN WITH ASD1
INTRA-HIPPOCAMPAL INJECTION OF ALPHA-SYNUCLEIN PRE-FORMED FIBRILS TRIGGERS COGNITIVE DEFECT AND CHANGES TRANSCRIPTOME PROFILES1
IS THERE AN OPTIMAL ELECTRODE PLACEMENT FOR PATIENTS WITH SCHIZOPHRENIA UNDERGOING ELECTROCONVULSIVE THERAPY?1
Five-factor personality traits in patients with schizophrenia and bipolar disorder: a systematic review and meta-analysis1
509. INVOLVEMENT OF THE GUT-BRAIN AXIS IN FOOD ADDICTION1
630. EPITRANSCRIPTOMIC REGULATION OF STRIATAL FUNCTION: A NEW NEUROBIOLOGY OF SCHIZOPHRENIA?1
Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects1
TRANSCRANIAL PULSE STIMULATION FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A RANDOMIZED, DOUBLE-BLIND, SHAM- CONTROLLED, PILOT TRIALS1
EFFECTS OF SMOKING CUES ON CORTICOSTRIATAL GLUTAMATE LEVELS IN NON-SMOKERS1
PROPOSAL FOR NOVEL PATIENT CLASSIFICATION WITH ENLARGED LATERAL VENTRICLES AND COGNITIVE DECLINE BASED ON DATA-DRIVEN ANALYSIS OF NEUROIMAGING IN PSYCHIATRIC DISORDERS AND CLINICAL CHARACTERIZATION1
CARBAMAZEPINE TOXICITY WITH COMPLETE OPHTHALMOPLEGIA1
363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR1
Distinct Situational Cue Processing in Individuals with Kleptomania: A Preliminary Study1
Retraction of: Mesenchymal Stem Cell–Derived Extracellular Vesicles Alleviate M1 Microglial Activation in Brain Injury of Mice With Subarachnoid Hemorrhage via microRNA-140-5p Delivery1
234. ANXIETY BEHAVIOR AND IMMUNE RESPONSE OF MICROGLIA IN RATS SUBJECTED TO STRESS THROUGH THE SYMPATHETIC NERVOUS SYSTEM1
REPURPOSING OF GAMMA-HYDROXYBUTYRATE IN DEPRESSION: A RANDOMIZED PLACEBO-CONTROLLED PROOF-OF-CONCEPT CLINICAL TRIAL1
THE AGE EFFECT UPON FNIRS MEASURED BRAIN FUNCTION BETWEEN SCHIZOPHRENIA PATIENTS AND NORMAL CONTROLS1
Towards an expanded neurocognitive account of ketamine’s rapid antidepressant effects1
SLOVAK PSYCHIATRISTS‘PERSPECTIVE ON THE ROLE OF PHARMACOGENETIC TESTING IN MENTAL HEALTH CARE1
RISK OF DEMENTIA IN CANCER SURVIVORS: A NATIONWIDE COHORT STUDY1
Nociceptin Receptor Antagonism Modulates Electrophysiological Markers of Reward Learning1
305. CT-152, A PRESCRIPTION DIGITAL THERAPEUTIC FOR MAJOR DEPRESSIVE DISORDER: A REAL-WORLD ANALYSIS OF DURABILITY OF TREATMENT EFFECT1
0.29815006256104